Professor of Pediatrics
Boston Children's Hospital / Dana-Farber Cancer Institute
Wendy B. London, PhD
Dr. London is a Professor of Pediatrics, Harvard Medical School, and the Director of Biostatistics in the Division of Pediatric Hematology/Oncology at Dana-Farber Cancer Institute and Boston Children’s Hospital. She is the Director of the Survey and Qualitative Methods Core, Dana-Farber/ Harvard Cancer Center. Dr. London was awarded her PhD in Biostatistics from Virginia Commonwealth University, Medical College of Virgina, in 1997. She has >25 years of experience in design, conduct, analysis, and reporting of clinical trials and biological studies in pediatric cancer, including several phase 3 trials in high-risk neuroblastoma that set a new standard of care during her tenure as Lead Statistician for the Children’s Oncology Group Neuroblastoma Committee (1998-2014). She chairs the Statistics Committee of the International Neuroblastoma Risk Groups (INRG) task force.
Dr. London is a member of the Cellular, Tissue, and Gene Therapies Advisory Committee of the Food and Drug Administration (2023-27) and the NIH/NCI Therapeutic Immune Regulation (TIR) Study Section (2022-26). She is a member of the editorial board of the Journal of the National Cancer Institute (2020-present), and was a member of the Journal of Clinical Oncology editorial board from 2013-2020. She is workshop co-chair of the American Association for Cancer Research/American Society of Clinical Oncology (AACR/ASCO) Methods in Clinical Cancer Research Workshop (the “Vail course”).